POINT: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY IN MULTIPLE MYELOMA: TANESPIMYCIN
USPTO (United States) · Serial 77795564
- Status
- abandoned
- Status updated
- 10 September 2012
- Filing date
- 3 August 2009
- Registration date
- -
- Nice classification
- 42
- Owner
- Bristol-Myers Squibb Company
- Owner country
- US
- Raw status code
- 606
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 77795564) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.